359 related articles for article (PubMed ID: 26134309)
1. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.
Kheirollahi M; Kazemi E; Ashouri S
Cell Mol Neurobiol; 2016 Jan; 36(1):1-10. PubMed ID: 26134309
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.
Xu MQ; St Clair D; Ott J; Feng GY; He L
Schizophr Res; 2007 Mar; 91(1-3):6-13. PubMed ID: 17289348
[TBL] [Abstract][Full Text] [Related]
3. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder.
Kanazawa T; Glatt SJ; Kia-Keating B; Yoneda H; Tsuang MT
Psychiatr Genet; 2007 Jun; 17(3):165-70. PubMed ID: 17417060
[TBL] [Abstract][Full Text] [Related]
5. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
7. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
[TBL] [Abstract][Full Text] [Related]
8. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.
Wang J; Zhang F; Zhu W; Liu Y; Zhou Z
Acta Neuropsychiatr; 2015 Dec; 27(6):327-35. PubMed ID: 26503495
[TBL] [Abstract][Full Text] [Related]
10. Exploring the association between BDNF Val66Met polymorphism and suicidal behavior: Meta-analysis and systematic review.
González-Castro TB; Salas-Magaña M; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Hernández-Díaz Y
J Psychiatr Res; 2017 Nov; 94():208-217. PubMed ID: 28756290
[TBL] [Abstract][Full Text] [Related]
11. The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.
González-Castro TB; Nicolini H; Lanzagorta N; López-Narváez L; Genis A; Pool García S; Tovilla-Zárate CA
Bipolar Disord; 2015 Feb; 17(1):27-38. PubMed ID: 25041243
[TBL] [Abstract][Full Text] [Related]
12. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.
Naoe Y; Shinkai T; Hori H; Fukunaka Y; Utsunomiya K; Sakata S; Matsumoto C; Shimizu K; Hwang R; Ohmori O; Nakamura J
Neurosci Lett; 2007 Mar; 415(2):108-12. PubMed ID: 17267117
[TBL] [Abstract][Full Text] [Related]
13. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
15. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
Suchanek R; Owczarek A; Paul-Samojedny M; Kowalczyk M; Kucia K; Kowalski J
J Neuropsychiatry Clin Neurosci; 2013; 25(1):88-94. PubMed ID: 23487199
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.
Gratacòs M; González JR; Mercader JM; de Cid R; Urretavizcaya M; Estivill X
Biol Psychiatry; 2007 Apr; 61(7):911-22. PubMed ID: 17217930
[TBL] [Abstract][Full Text] [Related]
18. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
[TBL] [Abstract][Full Text] [Related]
19. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis.
Kawashima K; Ikeda M; Kishi T; Kitajima T; Yamanouchi Y; Kinoshita Y; Okochi T; Aleksic B; Tomita M; Okada T; Kunugi H; Inada T; Ozaki N; Iwata N
Schizophr Res; 2009 Jul; 112(1-3):72-9. PubMed ID: 19406621
[TBL] [Abstract][Full Text] [Related]
20. BDNF Val66Met polymorphism in primary adult-onset dystonia: a case-control study and meta-analysis.
Gómez-Garre P; Huertas-Fernández I; Cáceres-Redondo MT; Alonso-Canovas A; Bernal-Bernal I; Blanco-Ollero A; Bonilla-Toribio M; Burguera JA; Carballo M; Carrillo F; Catalán-Alonso MJ; Escamilla-Sevilla F; Espinosa-Rosso R; Fernández-Moreno MC; García-Caldentey J; García-Moreno JM; García-Ruiz PJ; Giacometti-Silveira S; Gutiérrez-García J; Jesús S; López-Valdés E; Martínez-Castrillo JC; Martínez-Torres I; Medialdea-Natera MP; Méndez-Lucena C; Mínguez-Castellanos A; Moya M; Ochoa-Sepulveda JJ; Ojea T; Rodríguez N; Sillero-Sánchez M; Vargas-González L; Mir P
Mov Disord; 2014 Jul; 29(8):1083-6. PubMed ID: 24925604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
